Publication:
Design and validation of a predictive model for 1-year hospital admission in HIV patients on antiretroviral treatment

dc.contributor.authorMontes-Escalante, Ines
dc.contributor.authorMonje-Agudo, Patricia
dc.contributor.authorCalvo-Cidoncha, Elena
dc.contributor.authorAlmeida-Gonzalez, Carmen V.
dc.contributor.authorMorillo-Verdugo, Ramon
dc.contributor.authoraffiliation[Montes-Escalante, Ines] Nuestra Senora de Valme Hosp, Dept Pharm, Ave Bellavista S-N, Seville 41014, Spain
dc.contributor.authoraffiliation[Monje-Agudo, Patricia] Nuestra Senora de Valme Hosp, Dept Pharm, Ave Bellavista S-N, Seville 41014, Spain
dc.contributor.authoraffiliation[Calvo-Cidoncha, Elena] Nuestra Senora de Valme Hosp, Dept Pharm, Ave Bellavista S-N, Seville 41014, Spain
dc.contributor.authoraffiliation[Morillo-Verdugo, Ramon] Nuestra Senora de Valme Hosp, Dept Pharm, Ave Bellavista S-N, Seville 41014, Spain
dc.contributor.authoraffiliation[Almeida-Gonzalez, Carmen V.] Nuestra Senora de Valme Hosp, Invest Dept, Seville, Spain
dc.date.accessioned2023-02-12T02:21:45Z
dc.date.available2023-02-12T02:21:45Z
dc.date.issued2016-07-01
dc.description.abstractObjectives To develop and validate a model for predicting the risk of hospital admission within 1 year in the HIV population under antiretroviral treatment.Methods We conducted a retrospective observational study. Patients receiving antiretroviral treatment for at least 1 year who were followed by the pharmacy service in a Spanish-speaking hospital between January 2008 and December 2012 were included. Demographics, and clinical and pharmacotherapy variables, were included in the model design. To find prognostic factors for hospital admission a multivariate logistic regression model was created after performing a univariate analysis. Model validity was determined by the shrinkage method and the model discrimination by Harrell's C-index.Results 442 patients were included in the study. The variables 'CD4 count 50 copies/mL)', 'number of previous admissions', and 'number of drugs different from antiretroviral treatment' were the independent predictors of risk of hospital admission. Probabilities predicted by the model showed an R-2=0.98 for the development sample and an R-2=0.86 for the validation sample. The Harrell's C index for the development and validation data were 0.82 (95% CI 0.77 to 0.87) and 0.80 (95% CI 0.73 to 0.88), respectively.Conclusions The model developed in this study may be useful in daily practice for identifying HIV patients at high risk of 1-year hospital admission.
dc.identifier.doi10.1136/ejhpharm-2015-000788
dc.identifier.essn2047-9964
dc.identifier.issn2047-9956
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc6451448?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/19034
dc.identifier.wosID380230100009
dc.issue.number4
dc.journal.titleEuropean journal of hospital pharmacy
dc.journal.titleabbreviationEur. j. hosp. pharm.
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.number224-227
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.subjectDrug-interactions
dc.subjectRisk
dc.subjectComorbidity
dc.subjectReadmission
dc.subjectPolypharmacy
dc.titleDesign and validation of a predictive model for 1-year hospital admission in HIV patients on antiretroviral treatment
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number23
dc.wostypeArticle
dspace.entity.typePublication

Files